HIGHLIGHTS
- who: September et al. from the Naples Federico II, Italy have published the research: Nanoparticle-based drug delivery systems for the treatment of cardiovascular diseases, in the Journal: (JOURNAL)
- what: The aim of all treatment protocols for CVDs is to better promote blood supply and diminish tissue damage to minimize cardiomyocyte loss and increase contractile area.
SUMMARY
Heart failure, arrhythmia, atherosclerosis, coronary heart disease, myocardial infarction (MI), peripheral arterial disease, deep vein thrombosis, and inflammatory heart disease, along with other cardiovascular diseases (CVDs) are a primary cause of death worldwide. Nano . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.